BLASTS 10 PERCENT OR MORE OF BONE MARROW NUCLEATED CELLS
Clinical trials for BLASTS 10 PERCENT OR MORE OF BONE MARROW NUCLEATED CELLS explained in plain language.
Never miss a new study
Get alerted when new BLASTS 10 PERCENT OR MORE OF BONE MARROW NUCLEATED CELLS trials appear
Sign up with your email to follow new studies for BLASTS 10 PERCENT OR MORE OF BONE MARROW NUCLEATED CELLS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Heart shield: new study tests drug to prevent chemo side effects
Disease control Recruiting nowThis study tests whether a drug called dexrazoxane can protect the heart from damage caused by chemotherapy in people with certain blood cancers, like acute myeloid leukemia (AML) and high-risk myelodysplastic syndrome (MDS). About 100 participants will receive dexrazoxane alongs…
Matched conditions: BLASTS 10 PERCENT OR MORE OF BONE MARROW NUCLEATED CELLS
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 14, 2026 12:05 UTC
-
New drug cocktail shows promise for tough blood cancers
Disease control Recruiting nowThis study tests a combination of four chemotherapy drugs (cladribine, idarubicin, cytarabine, and venetoclax) in people with acute myeloid leukemia, high-risk myelodysplastic syndrome, or a fast-growing form of chronic myeloid leukemia. The goal is to see how well these drugs ki…
Matched conditions: BLASTS 10 PERCENT OR MORE OF BONE MARROW NUCLEATED CELLS
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Apr 24, 2026 16:20 UTC